Lifespan Research Institute

10/01/2026

Today is International Longevity Day.
At Lifespan Research Institute, this day is a reminder of the future we are working to build: one in which growing older does not have to mean an ever-increasing burden of disease.

The goal of human longevity research is not just to add years to life. It is to add healthy years. More time with the people we love, more independence, and more opportunity to create, contribute, and experience life.

That future will not come from a single discovery. It takes an ecosystem.

At LRI, we work across that ecosystem to drive the field forward on multiple fronts:
📰Educating through thousands of articles and resources
📈 Catalyzing millions in longevity biotech investment
🔬 Translating research toward the clinic
🤝 Building tools, advocacy, and collaborations

With the support of our community, we can do even more by:
🗺️ Expanding tools like our Rejuvenation Roadmap
🧬 Advancing therapies targeting mitochondrial dysfunction and senescent cells
📊 Developing digital biomarkers to better measure human aging
🤝 Building the connections that turn promising science into real-world impact

At a time when the future is so often described in terms of what may go wrong, we believe it is also worth investing in what can go right.

If you believe a healthier future is worth building, please stand with LRI this International Longevity Day.

💙 Support our work: lifespan.io/support

We welcome one-time and recurring donations, as well as gifts of stock, cryptocurrency, and through donor-advised funds. For larger gifts or potential matching support, please contact [email protected]

09/03/2026

Tim Maupin has spent years developing The Last Generation to Die, a near-future film about what happens when the first true rejuvenation technologies arrive.

07/20/2026

Thank you to the American Federation for Aging Research for their generous support and for joining the Lifespan Alliance!

AFAR is a nonprofit organization dedicated to supporting and advancing healthy aging through biomedical research. Since 1981, AFAR has funded scientists across critical stages of their careers and helped build the field of aging research.

As a new Lifespan Alliance member, we’re looking forward to collaborating with the AFAR team to strengthen the aging research ecosystem and help advance discoveries that support healthier, longer lives.

Check out their work:
https://www.afar.org/

Join the Lifespan Alliance:
https://lifespan.io/get-involved/lifespan-alliance/

07/17/2026

We’re happy to welcome NOVOS to the Lifespan Alliance, and appreciate their generous support!

NOVOS is a public benefit longevity biotechnology company translating advances in aging research into clinically studied consumer solutions designed to support longer, healthier lives.

We’re looking forward to collaborating with their team to expand access to evidence-based longevity tools and advance public understanding of aging science.

Check out what they’re working on:
https://novoslabs.com/

Join the Lifespan Alliance:
https://lifespan.io/get-involved/lifespan-alliance/

07/16/2026

We're glad to welcome Equator Therapeutics to our growing Lifespan Alliance, and appreciate their generous support!

Equator Therapeutics is developing a first-in-class therapy designed to activate mitochondrial thermogenesis, increase energy expenditure, and address obesity and related metabolic disorders.

As a new Lifespan Alliance member, we’re looking forward to collaborating with their team to advance progress at the intersection of mitochondrial biology, metabolic health, and longevity.

Check out what they’re working on:
https://equatortherapeutics.com/

Join the Lifespan Alliance:
https://lifespan.io/get-involved/lifespan-alliance/

06/22/2026

The 2060 Longevity Forum returns September 2–3, 2026, in Aix-en-Provence, France.

The forum brings together scientists, investors, founders, and policy advocates for two days focused on a central question: How do we fund the defeat of aging?

This year’s program includes Matthew O'Connor, Ole Mensching, Dylan Livingston, Keith Comito, Emil Kendziorra, Natasha Vita-More, Nader Yatim, Tom Zuber, and many others, with additional speakers soon to be announced.

The format is designed for practical exchange, with talks, startup pitches, investor speed networking, and focused discussion around the scientific, financial, and policy infrastructure needed to move longevity research forward.

Last year, the forum brought together 200 participants from 15 countries, including 100 investors, with $10M in intended transactions.

For the Lifespan.io community, the organizers are offering 50% off ticket prices with code LIFESPANIO2026.

The code is available until July 30.

Tickets: forum.2060.life

September the 2nd and 3rd, 2026, Aix en provence, France. 2060 Longevity forum is an 2 days longevity forum bringing the world's best minds together to extend human healthspan & solve aging.

05/02/2026

The Longevity Investor Network has published its look back on 2025. The LIN has grown, funded more early-stage biotech, and helped push aging research closer to real-world therapies.

Read more: https://ow.ly/hFCS50YTXYP

Support our programs like the LIN: https://ow.ly/qCPB50YTXYO

The Longevity Investor Network (LIN) was created to help bridge the gap between promising longevity startups and the investors capable of helping them scale.

04/10/2026

Longevity science is advancing fast, but is the public narrative keeping pace? This panel discussion at the Longevity Summit explores the public narrative around longevity science as represented in the media, and what this tells us about strategies to accelerate aging research going forward.

🔹 Conference: The Longevity Summit, organized by Longevity Global and held at the Buck Institute for Research on Aging.

🔹Panelists:
Keith Comito of Lifespan Research Institute
Gary J. Alan of ALSAE Foundation
Zara Stone of the The San Francisco Standard
Moderated by: Chris Patil of BioAge Labs

Longevity science is advancing fast, but is the public narrative keeping pace? At the Longevity Summit, Keith Comito of LRI, Gary J. Alan of ALSAE, and Zara ...

03/27/2026

For longevity science, the goal isn't just a longer life, but a better one. Yet how the field talks about that goal, to the public and to itself, is still a subject of debate. This panel from the Longevity Biomarkers Summit at Infinita City, Roatán digs into that question and more.

Panelists:
Tina Woods | Collider Health
Eric Verdin| CEO, Buck Institute for Research on Aging
Jasmine Smith | CEO, Rejuve.AI
Keith Comito| CEO & President, Lifespan Research Institute

Moderated by: Macsue Jacques, Decoding Longevity Podcast

Highlights:
► Health span vs. lifespan: do we actually need to choose?
► Is the longevity field "shooting ahead of its skis" and ways the field can earn public trust.
► What are the ways we can be ambitious in terms of advocating for maximal life extension, together with healthspan.
► The systemic, political, and economic barriers standing between us and longer, healthier lives, and ways to potentially overcome them.
► Why biomarkers might be the field's most underrated tool right now.
► GLP-1s, epigenetic reprogramming, Alzheimer's light therapy, and the one intervention that might already be free.

For longevity science, the goal isn't just a longer life, but a better one. Yet how the field talks about that goal, to the public and to itself, is still a ...

03/20/2026

Your phone might already be the most powerful longevity diagnostic tool you own. Keith Comito makes the case at the Longevity Biomarker Summit, organized by Rejuve.AI at InfinitaCity in Roatán. Full talk on YouTube now!

Keith describes emerging technologies capable of developing fast, cheap, and reliable digital biomarkers utilizing voice, face, and gait analysis, based on easy-to-collect audio and video data. He furthermore describes the utility of working with standards organizations such as the ASTM and NIST as a key approach to uniting the field in the development of composite biomarkers for non-invasively detectable functional fitness, and how this can facilitate the creation of clinical indications for age-related decline and the acceleration of all clinical trials generally.

Beyond clinical-grade kiosk units, mobile phones can collect required data types at scale, laying the ground work for powerful decentralized science possibilities, in addition to FDA-recognized endpoints and actionable clinical indications.

Would you contribute your voice and facial data to develop novel aging biomarkers?

Keith Comito, CEO and president of LRI, presents “The Clinic In Your Phone: Realizing the Promise of Digital Biomarkers and Games To Accelerate Geroscience” ...